{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:56:29Z","timestamp":1767135389830,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":18,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd004198.pub2","type":"reference-entry","created":{"date-parts":[[2004,10,14]],"date-time":"2004-10-14T10:08:51Z","timestamp":1097748531000},"source":"Crossref","is-referenced-by-count":11,"title":["Treatments for priapism in boys and men with sickle cell disease"],"prefix":"10.1002","author":[{"given":"Francis I","family":"Chinegwundoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kofi A","family":"Anie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,10,18]]},"reference":[{"issue":"Suppl","key":"10.1002\/14651858.CD004198.pub2-BIB1|cit1","first-page":"39","article-title":"Stilboestrol and stuttering priapism in homozygous sickle-cell disease [abstract]","volume":"35","author":"Serjeant","year":"1986","journal-title":"West Indian Medical Journal"},{"issue":"8467","key":"10.1002\/14651858.CD004198.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0140-6736(85)91555-7","article-title":"Stilboestrol and stuttering priapism in homozygous sickle-cell disease","volume":"2","author":"Serjeant","year":"1985","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004198.pub2-BIB3|cit3","unstructured":"Olujohungbe A A randomised double blind placebo controlled trial of oral ephedrine and etilefrine in the prevention of recurrent (stuttering) attacks of priapism in sickle cell disease: A multicentre International study in older children and adults Personal communication 2005"},{"key":"10.1002\/14651858.CD004198.pub2-BIB4|cit4","first-page":"14a","article-title":"Two years experience in management of priapism and impotence in sickle cell disease [abstract]","volume":"88","author":"Bachir","year":"1996","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD004198.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0022-5347(17)34928-5","article-title":"Anoxia and smooth muscle dysfunction: a model for ischaemic priapism","volume":"151","author":"Broderick","year":"1994","journal-title":"Journal of Urology"},{"issue":"7109","key":"10.1002\/14651858.CD004198.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/bmj.315.7109.656","article-title":"The management of patients with sickle cell disease","volume":"315","author":"Davies","year":"1997","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD004198.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analysis involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"11","key":"10.1002\/14651858.CD004198.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1001\/archinte.1980.00330220022011","article-title":"Priapism and impotence in homozygous sickle cell disease","volume":"140","author":"Emond","year":"1980","journal-title":"Archives of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD004198.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1046\/j.1365-2141.1999.01275.x","article-title":"Mapping the prevalence of sickle cell and beta thalassaemia in England: estimating and validating ethnic-specific rates","volume":"104","author":"Hickman","year":"1999","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD004198.pub2-BIB10|cit10","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008] The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org","DOI":"10.1002\/9780470712184"},{"key":"10.1002\/14651858.CD004198.pub2-BIB11|cit11","first-page":"1155","article-title":"Physiology of penile erection and pathophysiology of erectile dysfunction and priapism","volume-title":"Campbell's Urology","volume":"2","author":"Lue","year":"1998"},{"issue":"6","key":"10.1002\/14651858.CD004198.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/00043426-199911000-00013","article-title":"Prevalence of priapism in children and adolescents with sickle cell anaemia","volume":"21","author":"Mantadakis","year":"1999","journal-title":"Journal of Paediatric Hematology\/Oncology"},{"key":"10.1002\/14651858.CD004198.pub2-BIB13|cit13","unstructured":"National Institutes of Health USA The Management of Sickle Cell Disease Division of Blood Disease and Resources, National Heart, Lung and Blood Institute 2002"},{"issue":"3","key":"10.1002\/14651858.CD004198.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1046\/j.1365-2141.2002.03691.x","article-title":"Etilefrine for the prevention of priapism in adult sickle cell disease","volume":"118","author":"Okpala","year":"2002","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD004198.pub2-BIB15|cit15","unstructured":"The Cochrane Collaboration Review Manager (RevMan) 2008"},{"issue":"4","key":"10.1002\/14651858.CD004198.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0090-4295(97)00704-8","article-title":"Penile implant for intractable priapism associated with sickle cell disease","volume":"51","author":"Upadhyay","year":"1998","journal-title":"Urology"},{"issue":"5","key":"10.1002\/14651858.CD004198.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0090-4295(96)00027-1","article-title":"Preventive treatment of priapism in sickle cell disease with oral and self-administered intracavernous injection of etilefrine","volume":"47","author":"Virag","year":"1996","journal-title":"Urology"},{"key":"10.1002\/14651858.CD004198.pub2-BIB18|cit18","unstructured":"World Health Organisation Joint WHO\/TIF Meeting on the Control of Haemoglobinopathies. Report of the 7th Meeting of the WHO Working Group on the Control of Hereditary Anaemias; 1994 April 3-4; Nicosia, Cyprus Unpublished document WHO\/HDP\/TIF\/HA\/93.1 1994"}],"updated-by":[{"DOI":"10.1002\/14651858.cd004198.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T00:00:00Z","timestamp":1505779200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD004198.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:31:38Z","timestamp":1628530298000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD004198.pub2"}},"subtitle":[],"editor":[{"given":"Francis I","family":"Chinegwundoh","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2004,10,18]]},"references-count":18,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004198.pub2","relation":{},"subject":[],"published":{"date-parts":[[2004,10,18]]}}}